Leontis equity fund GmbH makes investments in future-oriented sectors Wurzburg, in January 2010: biotechnology and clean energy are sectors that continue are gaining in the future for example through the development of new medicines, or environmentally-friendly technologies. The Leontis equity fund GmbH has recognized the trend and with the Leontis equity funds recently two companies from these sectors participated. Revolutionary, new products from biotechnology can change people’s lives. The so-called medical pharmaceutical”branch is considered the largest and most important branch of biotechnology. The goal in this industry is the development of new drugs for the treatment of serious diseases. Scientists are already researching medicines to relieve or cure major common diseases such as cancer, rheumatism, and various viral diseases.

The sector clean energy is also an growing and therefore promising industrial sector. This ecologically-oriented industry located worldwide in the Upward trend on the one hand due to the growing demand for energy (such as by growing markets such as China), on the other hand also by an increased sensitivity of consumers in relation to environmental issues. Both industries of the future, biotechnology as clean energy, offer investors great opportunities to benefit from positive market developments. The Leontis equity fund GmbH has been involved therefore with the Leontis equity fund premium select I GmbH & co. KG in these growing markets, RAPID of the biotechnology companies Pharmaceuticals AG. Moreover, the Leontis equity fund premium select I GmbH & co. has KG in terms of clean energy to the Robeco clean tech private equity II, L.P. involved.

Including the investment in technologies for the production of renewable energies such as solar, biofuels, wind, water, heat and energy production from biomass and recycling of materials is the focus of this participation. 2012, the company plans the launch of a treatment against AIDS. About Leontis equity fund GmbH is the Leontis equity fund GmbH Initiator and provider of high-quality, structured investments in the form of closed-end funds. The company was founded in 2006. “” Since July 2008 Leontis provides already the successor fund Leontis equity fund easy select II “and Leontis equity fund premium select II” on. The Leontis concept allows investors access to exclusive top investments. The management of Leontis equity funds has many years of experience and competence in the design and management of closed funds products. Also the star-studded investment and advisory councils of Leontis equity fund GmbH bring decades of industry expertise.